Autoimmune Clinical Trials in Beijing, Beijing Municipality
14 recruitingBeijing, Beijing Municipality, China
Showing 1–14 of 14 trials
Recruiting
Phase 1
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single- and Multiple-Ascending Doses and Food Effect of BGB-45035 in Healthy Participants and in Adults With Autoimmune Dermatological Diseases
healthy adult participantsHealthy ParticipantsHealthy Volunteers+4 more
BeiGene211 enrolled13 locationsNCT06342713
Recruiting
Phase 1Phase 2
Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory Autoimmune Diseases
Autoimmune Diseases
Beijing GoBroad Hospital18 enrolled1 locationNCT06688799
Recruiting
Phase 2
Exploratory Study of Anti-BCMA-CD19 CAR-T Cell Therapy in Relapsed or Refractory IgG4-Related Disease
B-cell Mediated Autoimmune DisordersIgG4-related Disease
Chinese PLA General Hospital9 enrolled1 locationNCT07148791
Recruiting
Phase 1
Inaticabtagene Autoleucel Injection in the Treatment of Refractory Systemic Lupus Erythematosus-related Immune Thrombocytopenia
Autoimmune Thrombocytopenia
Juventas Cell Therapy Ltd.12 enrolled1 locationNCT06826430
Recruiting
Not Applicable
Sirolimus in the Treatment of Refractory/Relapsed wAIHA
Warm Autoimmune Hemolytic Anemia
Peking Union Medical College Hospital22 enrolled1 locationNCT05925023
Recruiting
Not Applicable
Autologous CD19CAR-T Therapy for Recurrent/Refractory Autoimmune Diseases
Autoimmune Disease
Beijing Boren Hospital12 enrolled1 locationNCT06993493
Recruiting
Not Applicable
Safety and Efficacy of CD19 CAR-T Therapy for Recurrent/Refractory Autoimmune Diseases
Autoimmune Disease
Beijing Boren Hospital12 enrolled1 locationNCT06983964
Recruiting
Study on AI-assisted Multimodal Diagnosis System of Autoimmune Pancreatitis
Autoimmune Pancreatitis
Peking Union Medical College Hospital180 enrolled1 locationNCT06369909
Recruiting
Phase 1Phase 2
Sequential CAR-T Cells Targeting BCMA/CD19 in Patients With Relapsed/ Refractory Autoimmune Diseases
Systemic Lupus ErythematosusSjogren's SyndromeAutoimmune Diseases+1 more
Essen Biotech60 enrolled1 locationNCT06428188
Recruiting
Phase 1Phase 2
Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE)
Systemic Lupus ErythematosusAnti-Neutrophil Cytoplasmic Antibody-Associated VasculitisSjogren's Syndrome+6 more
Essen Biotech75 enrolled1 locationNCT06350110
Recruiting
National, Multicentric Registry Study on Neuroimmunological Diseases in China
Myasthenia GravisAutoimmune EncephalitisMultiple Sclerosis+3 more
Xuanwu Hospital, Beijing7,000 enrolled1 locationNCT06443333
Recruiting
Observational Study of Pediatric Rheumatic and Immunologic Diseases in China: The CAPRID Registry
Autoimmune DiseasesAutoinflammatory Diseases
Peking Union Medical College Hospital20,000 enrolled9 locationsNCT06417502
Recruiting
Phase 2
Zanubrutinib in the Treatment of Relapsed/Refractory wAIHA
Warm Autoimmune Hemolytic Anemia
Chen Miao22 enrolled1 locationNCT05922839
Recruiting
China National Registry of Neuro-Inflammatory Diseases
Multiple SclerosisClinically Isolated SyndromeAcute Disseminated Encephalomyelitis+4 more
Beijing Tiantan Hospital10,000 enrolled1 locationNCT05154370